Zhou ZG - Search Results

1

Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.

Wang XH, Liu QB, Xiang CL, Mao XH, Yang B, Li Q, Zhou QF, Li SQ, Zhou ZG, Chen MS. Wang XH, et al. Among authors: zhou qf, zhou zg. Int J Cancer. 2021 Jul 1;149(1):127-138. doi: 10.1002/ijc.33516. Epub 2021 Feb 27. Int J Cancer. 2021. PMID: 33586134 Free article.

2

[Prognosis of rectal cancer patients after total mesorectal excision].

Pan ZZ, Ding PR, Wan DS, Li LR, Wu XJ, Lu ZH, Kong LH, Lin JZ, Zhou ZG. Pan ZZ, et al. Among authors: zhou zg. Ai Zheng. 2009 Sep;28(9):903-7. doi: 10.5732/cjc.008.10804. Ai Zheng. 2009. PMID: 19728904 Free article. Chinese.

3

[Prognostic analysis of 443 cases of stage II colorectal cancer and the value of adjuvant chemotherapy].

Zhou ZG, Pan ZZ, Wan DS, Li LR, Wu XJ, Ding PR, Lin JZ, Peng ZH. Zhou ZG, et al. Ai Zheng. 2009 Sep;28(9):908-12. doi: 10.5732/cjc.008.10802. Ai Zheng. 2009. PMID: 19728905 Free article. Chinese.

4

Clinicopathologic factors predicting outcomes in patients with gastrointestinal stromal tumors of the rectum and colon.

Zhou Z, Chen Z, Chen M, Wang R, Yin Y, Yao Y. Zhou Z, et al. Tumour Biol. 2014 May;35(5):4357-62. doi: 10.1007/s13277-013-1572-7. Epub 2013 Dec 28. Tumour Biol. 2014. PMID: 24375257

5

Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib.

Xu L, Gao H, Huang J, Wang H, Zhou Z, Zhang Y, Li S, Chen M. Xu L, et al. J Gastroenterol Hepatol. 2015 Jun;30(6):1032-9. doi: 10.1111/jgh.12910. J Gastroenterol Hepatol. 2015. PMID: 25639513

6

Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization.

Zhou ZG, Zheng XR, Zhou Q, Shi M, Zhang YJ, Guo RP, Yuan YF, Chen MS, Lin XJ, Lao XM, Li SP. Zhou ZG, et al. Among authors: zhou q. Chin J Cancer. 2015 May 14;34(5):205-16. doi: 10.1186/s40880-015-0017-7. Chin J Cancer. 2015. PMID: 26058595 Free PMC article.

7

A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection - first announcement of the protocol.

Qiu SJ, Zhou ZG, Shen F, Li AJ, Chen MS, Ying MG, Chen Z, Zhang YX, Sun HC, Fan J. Qiu SJ, et al. Among authors: zhou zg. Expert Opin Biol Ther. 2015;15 Suppl 1:S133-7. doi: 10.1517/14712598.2015.1039979. Epub 2015 Jun 22. Expert Opin Biol Ther. 2015. PMID: 26094695 Clinical Trial.

8

TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma.

Zhou DS, Wang HB, Zhou ZG, Zhang YJ, Zhong Q, Xu L, Huang YH, Yeung SC, Chen MS, Zeng MS. Zhou DS, et al. Among authors: zhou zg. Oncotarget. 2015 Sep 15;6(27):24163-77. doi: 10.18632/oncotarget.4643. Oncotarget. 2015. PMID: 26219398 Free PMC article.

9

A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma.

Zhou D, Zhang Y, Xu L, Zhou Z, Huang J, Chen M. Zhou D, et al. Sci Rep. 2015 Oct 21;5:15263. doi: 10.1038/srep15263. Sci Rep. 2015. PMID: 26486016 Free PMC article.

10

A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma.

Jiang SS, Tang Y, Zhang YJ, Weng DS, Zhou ZG, Pan K, Pan QZ, Wang QJ, Liu Q, He J, Zhao JJ, Li J, Chen MS, Chang AE, Li Q, Xia JC. Jiang SS, et al. Among authors: zhou zg. Oncotarget. 2015 Dec 1;6(38):41339-49. doi: 10.18632/oncotarget.5463. Oncotarget. 2015. PMID: 26515587 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

594 results

Search Page